KDM6B and cardiac hypertrophy: In the context of cardiac hypertrophy, JMJD3 raises beta-myosin heavy chain (β-MHC) levels by demethylating H3K27me3 at β-MHC's promoter, thereby contributing to cardiac hypertrophy [100].